hrp0098p2-220 | Pituitary, Neuroendocrinology and Puberty | ESPE2024

Association between Attention Deficit Hyperactivity Disorder, Precocious Puberty and Obesity in Korean girls

Byoul Lee Eun , Chung Sochung , Hee Hong Yong

Objective: Obesity has been reported to be associated with both attention deficit hyperactivity disorder (ADHD) and central precocious puberty. The purpose of the current study was to examine the prevalence of ADHD in girls with central precocious puberty and to compare body mass index (BMI) of the girls with ADHD and CPP together and the girls with CPP alone.Method: Girls with central precocious puberty were prospective...

hrp0098p2-115 | Fat, Metabolism and Obesity | ESPE2024

Changes in Weight Distribution & Trends in Obesity Prevalence among Children and Adolescents in East Asia: Insights from NCD-RisC Data

Hee Hong Yong , Park Sujin , Chung Sochung , Shin Minsoo , Jung Jahye , Sul Ah-Ram , Lee Yoon

Background: The worldwide prevalence of pediatric obesity has increased in recent decades, also in East Asia with environmental and lifestyle changes. Due to differences in obesity definitions and country-specific growth charts, direct comparisons of obesity prevalence across countries may not be appropriate. We aimto analyze the changes in weight distribution and the trends and patterns of pediatric obesity in China, Japan, South Korea, and Taiwan using WHO c...

hrp0098p2-361 | Late Breaking | ESPE2024

Assessment of Growth Hormone Treatment in Korean Pediatric Growth Disorders: 11-Year Interim Analysis from the LG Growth Study

Hee Hong Yong , Kim Jaehyun , Chae Hyun-Wook , Ah Lee Young , Sang Lee Hae , Mi Kim Yoo , Hye Kim Ja , Bae Ahn Moon , Rhie Young-Jun

Objectives: This study aim ed to evaluate the safety and effectiveness of recombinant human growth hormone (rhGH) treatment, using specific products (Eutropin®, Eutropin®Pen, Eutropin®AQ, Eutropin®Plus and Eutropin®SPen; LG Chem, Ltd.), in pediatric patients with growth disorders in Korea.Methods: The safety analysis included all eligible patients who received at least one dose of rhGH. The effectiven...